Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

fibronectin glomerulopathy News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A 17-year clinical course study demonstrates successful management of late-onset nephrotic syndrome in patients with FN1-associated fibronectin glomerulopathy. This research highlights the potential for long-term control of this rare condition.

A case report highlights the occurrence of concomitant fibronectin glomerulopathy and chronic active antibody-mediated rejection in a renal allograft. This study contributes to the understanding of complex renal transplant complications.

Not rare diseases news,news about your rare disease.

Earlier

A 17-year clinical course study demonstrates successful management of late-onset nephrotic syndrome in patients with FN1-associated fibronectin glomerulopathy. This research highlights the potential for long-term control of this rare condition.

A case report highlights the occurrence of concomitant fibronectin glomerulopathy and chronic active antibody-mediated rejection in a renal allograft. This study contributes to the understanding of complex renal transplant complications.

Not rare diseases news,
news about your rare disease.